Advertisement

Alopezie nach Chemotherapie

  • P. Schöffski

Zusammenfassung

Alopezie ist eine der häufigsten unerwünschten Behandlungsfolgen nach einer Chemo- oder Strahlentherapie. Der Ausfall der Kopfbehaarung geht oft einher mit einer Stigmatisierung des Patienten, beeinflußt in der ohnehin komplexen Behandlungsphase wichtige zwischenmenschliche Beziehungen, stört das soziale Gefüge und beeinträchtigt das „body image“. Alopezie ist die dem Laien bekannteste Nebenwirkung einer Chemotherapie und wird oft als charakteristisches Symptom einer Tumorerkrankung fehlinterpretiert. Die tumorbedingte Alopezie (Alopecia neoplastica) ist ein sehr seltenes Phänomen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bachelor D (2001) Hair and cancer chemotherapy: consequences and nursing care — a literature study. Eur J Cancer Care 10(3):147–163CrossRefGoogle Scholar
  2. Botchkarev VA, Komarova EA, Siebenhaar F et al (2000) p53 is essential for chemotherapy-induced hair loss. Cancer Res 60(18):5002–5006PubMedGoogle Scholar
  3. Cece R, Cazzaniga S, Morelli D, Sfondrini L et al (1996) Apoptosis of hair follicle cells during doxorubicin-induced alopecia. Lab Invest 75(4):601–609PubMedGoogle Scholar
  4. Christodoulou C, Klouvas G, Efstahiou E et al (2002) Effectiveness of the MSC cold cap system in the prevention of chemotherapy-induced alopecia. Oncology 62(2):97–102PubMedCrossRefGoogle Scholar
  5. Coates A, Abraham S, Kaye SB et al (1983) On the receiving end — patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol 19(2):203–208PubMedCrossRefGoogle Scholar
  6. Davis ST, Benson BG, Bramson HN et al (2001) Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors. Science 291(5501):134–137PubMedCrossRefGoogle Scholar
  7. Katsimbri P, Barnias A, Pavlidis N (2000) Prevention of chemotherapy-induced alopecia using an effective scalp cooling system. Eur J Cancer 36(6):766–771PubMedCrossRefGoogle Scholar
  8. Kim HJ, Min HG, Lee ES (1999) Alopecia neoplastica in a patient with gastric carcinoma. Br J Dermatol 141(6):1122–1124PubMedCrossRefGoogle Scholar
  9. McGarvey EL, Baum LD, Pinkterton RC, Rogers LM (2001) Psychological sequelae and alopecia among women with cancer. Cancer Pract 9(6):283–289PubMedCrossRefGoogle Scholar
  10. Passis SD, Kirsh KL, Rosenfeld B et al (2001) The changeable nature of patients’ fears regarding chemotherapy: implications for palliative care. J Pain Symptom Manage 21(2):113–120CrossRefGoogle Scholar
  11. Peters EM, Foitzik K, Paus R et al (2001) A new strategy for modulating chemotherapy-induced alopecia, using PTH/PTHrP-receptor agonists and antagonists. J Invest Dermatol 117(2):173–178PubMedCrossRefGoogle Scholar
  12. Ron IG, Kalmus Y, Kalmus Z et al (1997) Scalp cooling in the prevention of alopecia in patients receiving depilating chemotherapy. Support Care Cancer 5(2):136–138PubMedCrossRefGoogle Scholar
  13. Sato N, Leopold PL, Crystal RG (2001) Effect of adenovirus-mediated expression of sonic hedgehog gene on hair regrowth in mice with chemotherapy-induced alopecia. J Natl Cancer Inst 93(24):1858–1864PubMedCrossRefGoogle Scholar
  14. Wagner L, Bye MG (1979) Body image in patients experiencing alopecia as a result of cancer chemotherapy. Cancer Nurs 2(5):365–369PubMedCrossRefGoogle Scholar
  15. Williams J, Wood C, Cunningham-Warburton P (1999) A narrative study of chemotherapy-induced alopecia. Oncol Nurs Forum 26(9):1463–1468PubMedGoogle Scholar
  16. Witman G, Cadman E, Chen M (1981) Misuse of scalp hypothermia. Cancer Treat Rep 65:507–508PubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag Heidelberg 2006

Authors and Affiliations

  • P. Schöffski

There are no affiliations available

Personalised recommendations